AI Healthcare Scribe Developer Secures $100 Million
Healthcare operators can now leverage new automation tools to reclaim clinical time lost to administrative record-keeping.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Do you trust AI-powered assistants to accurately handle medical documentation for your own care?
AI healthcare firm Tandem Health has secured $100 million in Series B funding to scale its automated clinical documentation software. The Stockholm-based company, which serves 10,000 care organizations globally, aims to reduce the administrative burden on clinicians.
Why it matters
Clinicians currently dedicate approximately 40 percent of their working time to administrative tasks, creating a massive efficiency gap for healthcare operators. This capital infusion supports the scaling of AI tools designed to automate documentation and diagnosis coding across diverse medical record systems.
Tandem Health raised $100 million in its Series B round, doubling the $50 million secured in its Series A and bringing total capital to $160 million. Its software is currently utilized by 10,000 care organizations across 14 countries, integrating with over 130 existing medical record systems.
The players
Tandem Health
A Stockholm-based health tech firm providing AI-driven documentation tools for clinical environments.
Juvoly
A Dutch firm specializing in AI-based scribe technology, acquired by Tandem Health in early 2026.
T.Capital
A corporate venture arm providing strategic investment to support Tandem Health’s expansion.
LG Technology Ventures
The venture capital investment arm of LG Group that provides capital and global market expertise.
Norrsken VC
A venture capital firm focused on impact-driven investments, participating in Tandem Health’s latest round.
The details
Tandem Health's platform utilizes AI to listen to patient consultations, automatically generating documentation and coding diagnoses in real-time. By integrating with existing medical record systems, the software allows clinicians to bypass manual entry during patient encounters. The company has achieved Class IIa medical device certification under EU regulations, confirming its clinical utility for supporting decision-making and patient flow.
Timeline
2023: Tandem Health was founded in Stockholm.
Early 2026: Tandem Health acquired the Dutch AI scribe firm Juvoly.
September 2026: The company raised $100 million in Series B funding.
October 2026: Tandem announced new strategic investors, including T.Capital, LG Technology Ventures, and Norrsken VC.
Market Landscape
Tandem Health’s strategy follows the broader industry push to reclaim time lost to administrative burdens, a problem where clinicians currently spend 40 percent of their shift on documentation. This funding round positions the firm to compete for market share in the rapidly expanding clinical AI scribe sector.
Healthcare operators should evaluate whether integrating automated scribe software can measurably increase patient throughput or clinician retention. Focus procurement assessments on system interoperability, specifically checking compatibility with the 130-plus medical record systems Tandem currently supports.
The takeaway
The primary operational goal for Tandem is to return one billion working hours to European clinicians through automation. Operators should monitor the impact of this expansion on clinical workflow efficiency as a benchmark for future digital transformation investments.
Further reading
For broader trends in clinical operational efficiency, see the latest analysis in Healthcare.
Live Poll
Do you trust AI-powered assistants to accurately handle medical documentation for your own care?
